Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Johnson & Johnson Stock a Buy?


Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) isn't flashy. Frankly, it's a boring stock that chugs along over the years. But that doesn't make it a boring investment. Share prices of J&J stock are up more than 13,000% over the past five decades on price alone. That becomes a total return of more than 41,000% had you reinvested your dividends along the way.

The company has gone through some big changes over the past year. It spun off its consumer products segment as Kenvue (NYSE: KVUE). It proposed a multibillion-dollar settlement for tens of thousands of its litigation cases surrounding allegations of health concerns over its talcum-based baby powder.

So is this stock set to resume its wealth-compounding trajectory moving forward? 

Continue reading


Source Fool.com

Like: 0
JNJ
Teilen

Kommentare